Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
![412 - Assessing the use of multi-indication medicines](https://www.ohe.org/wp-content/uploads/2015/05/412-Assessing-the-use-of-multi-indication-medicines_0.jpg)
Optimal innovation balances willingness and ability to pay with the benefits of future R&D. Our wide-ranging programme aims to promote innovation in health care, increase our understanding of its value, and encourage R&D. New models of innovation should streamline development, reduce costs, and speed patient benefit.